INVO Bioscience Inc (INVO)
0.86
-0.06
(-7.02%)
USD |
NASDAQ |
May 06, 14:30
INVO Bioscience Total Assets (Quarterly): 20.89M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.89M |
| September 30, 2023 | 19.48M |
| June 30, 2023 | 6.639M |
| March 31, 2023 | 6.151M |
| December 31, 2022 | 4.104M |
| September 30, 2022 | 4.678M |
| June 30, 2022 | 6.425M |
| March 31, 2022 | 8.520M |
| December 31, 2021 | 10.47M |
| September 30, 2021 | 8.146M |
| June 30, 2021 | 9.931M |
| March 31, 2021 | 10.19M |
| December 31, 2020 | 10.95M |
| September 30, 2020 | 1.689M |
| June 30, 2020 | 2.306M |
| March 31, 2020 | 0.9579M |
| December 31, 2019 | 1.796M |
| Date | Value |
|---|---|
| September 30, 2019 | 2.565M |
| June 30, 2019 | 3.396M |
| March 31, 2019 | 3.503M |
| December 31, 2018 | 0.7773M |
| September 30, 2018 | 0.92M |
| June 30, 2018 | 1.143M |
| March 31, 2018 | 0.3077M |
| December 31, 2017 | 0.2664M |
| September 30, 2017 | 0.2004M |
| June 30, 2017 | 0.1818M |
| March 31, 2017 | 0.1945M |
| December 31, 2016 | 0.2862M |
| September 30, 2016 | 0.3895M |
| June 30, 2016 | 0.455M |
| March 31, 2016 | 0.5493M |
| December 31, 2015 | 0.5798M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.9579M
Minimum
Mar 2020
20.89M
Maximum
Dec 2023
7.33M
Average
6.425M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 73.21B |
| Perspective Therapeutics Inc | 97.89M |
| Xtant Medical Holdings Inc | 92.61M |
| Asensus Surgical Inc | 59.09M |
| Catheter Precision Inc | 30.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.00M |
| Shareholders Equity (Quarterly) | 0.8928M |
| Debt to Equity Ratio | 3.096 |
| Current Ratio | 0.1533 |
| Net Debt Paydown Yield | -16.43% |